Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity, today announced that Jayson Dallas, M.D., chief executive ...

The company, which provides cellular software services for an enterprise clientele, has raised $20m in 'strategic' growth ...

The domestic startup ecosystem is expected to rebound with fresh approaches in key sectors like content, media, fintech, and ...